Nissan Chemical Corp Investors Roundup Briefing Transcript
Thank you very much for joining us today despite your busy schedule. Prior to the presentation, let me start with a few comments. Recently regarding the lawsuits on ROUNDUP in the United States, we have been receiving a number of questions from investors and analysts. We tried to respond to each question in good faith. However, due to the time constraints in business briefings or results meetings, our explanations might not have been sufficient. Therefore, today, we have a sincere appreciation for your participation. We would like to explain in detail, taking sufficient time.
First, let me remind you that this is a fact-based reporting, and we minimized our forecast and interpretations of the company this time. We sincerely hope you to evaluate based on the scientific analysis.
Now let me start my presentation. Please turn to the table on Page 3 for sales. There may be some overlap with the information we already provided at the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |